Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation

Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation

10.1097/01.tp.0000166921.14670.33

Saved in:

Bibliographic Details
Main Authors:	Vathsala, A, Ona, ET, Tan, SY, Suresh, S, Lou, HX, Casasola, CBC, Wong, HC, Machin, D, Chiang, GSC, Danguilan, RA, Calne, R
Other Authors:	SURGERY
Format:	Article
Published:	Ovid Technologies (Wolters Kluwer Health) 2022
Subjects:	Adolescent Adult Aged Alemtuzumab Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antibodies, Neoplasm Cyclosporine Female Graft Rejection Humans Immunotherapy Kidney Kidney Function Tests Kidney Transplantation Male Middle Aged Time Factors
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/229456
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Be the first to leave a comment!